Preclinical Oncology Platforms​

We develop innovative preclinical models and services that enable informed decision making and compound evaluation. De-risk drug development and move your therapeutic into the clinic faster.
JAX Preclinical Services offers the most translational and predictive efficacy, pharmacokinetics (PK) and safety testing for therapeutics such as monoclonal antibodies, bispecifics, CAR-T, antibody-drug conjugates, and combination therapies.
By combining genetically defined tumors with innovative humanized mouse models, JAX enables the validation of therapeutic candidates in an array of in vivo platforms that better recapitulate the human condition.

Learn More About The
Jackson Laboratory's Oncology

Watch our on-demand webinar on humanized platforms for mAb, bispecific, and CAR-T therapeutics to see how JAX's models and services can produce the most predictive and translationally-relevant data for your next IND

Watch the Video

Not what you're looking for?
Visit our Resource Hub

Discover More

Sign up | JAX Pulse

Stay informed about our events, blogs and videos, and cutting-edge research platforms.